However, AT1R expression was significantly increased in LV tissue, which may support the benefit of using ACE inhibitors or AT1R blockers to delay cardiac dysfunction and concomitant fibrosis in DMD patients. This evidence concerns the gene AGTR1 and Duchenne muscular dystrophy.